Sensitivity of immunochemical faecal occult blood testing for detecting left-vs right-sided colorectal neoplasia

British Journal of Cancer

Volumn 104, Issue 11, 2011, Pages 1779-1785

  Haug, U ^a   Kuntz, K M ^b   Knudsen, A B ^c   Hundt, S ^a   Brenner, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

colorectal neoplasia; faecal occult blood testing; screening

Indexed keywords

ARTICLE; CANCER LOCALIZATION; COLONOSCOPY; COLORECTAL CANCER; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 79957589518     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.160     Document Type: Article

References (33)

1. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL (2008) Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 149: 441-450
2. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L (2009) Association of colonoscopy and death from colorectal cancer: a population-based, case-control study. Ann Intern Med 150: 1-8
3. Blatt LJ (1961) Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum 4: 277-282
4. Brenner H, Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister M (2007) Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case-control study. Cancer Epidemiol Biomarkers Prev 16: 494-499 (Pubitemid 46548652)
5. Brenner H, Haug U, Hundt S (2010a) Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 127: 1643-1649
6. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U (2010b) Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102: 89-95
7. Ciatto S, Martinelli F, Castiglione G, Mantellini P, Rubeca T, Grazzini G, Bonanomi AG, Confortini M, Zappa M (2007) Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 96: 218-221 (Pubitemid 46160624)
8. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristics curves: a non-parametric approach. Biometrics 44: 837-845
9. Eide TJ, Stalsberg H (1978) Polyps of the large intestine in Northern Norway. Cancer 42: 2839-2848 (Pubitemid 9107564)
10. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-1477 (Pubitemid 26400242)
11. Haug U, Hundt S, Brenner H (2010) Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 105: 682-690
12. Heresbach D, Barrioz T, Lapalus MG, Coumaros D, Bauret P, Potier P, Sautereau D, Boustière C, Grimaud JC, Barthélémy C, Sée J, Serraj I, D'Halluin PN, Branger B, Ponchon T (2008) Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 40: 284-290 (Pubitemid 351524375)
13. Heresbach D, Djabbari M, Riou F, Marcus C, Le Sidaner A, Pierredon-Foulogne MA, Ponchon T, Boudiaf M, Seyrig JA, Laumonier H, Luet D, Giraud-Cohen M, Pelletier AL, Charachon A, Ramaholimihaso F, Bouillet P, Veyrac M, Ficarelli S, Vahedi K, Keruhel J, Lamouliatte H, Ridereau-Zins C, Bouhnik Y, Tissier M, Diris B, Zagdanski AM, Josselin JM, Hamonic S, Gandon Y (2011) Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut 60(5): 658-665
14. Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B (2006) Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 18: 427-433
15. Hundt S, Haug U, Brenner H (2009) Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 150: 162-169
16. Jorgensen OD, Kronborg O, Fenger C (2002) A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50: 29-32 (Pubitemid 34028299)
17. Lakoff J, Paszat LF, Saskin R, Rabeneck L (2008) Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 6: 1117-1121
18. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y (2007) A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146: 244-255 (Pubitemid 351650610)
19. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Lieberman N, Klang S, Niv Y (2009) Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am J Gastroenterol 104: 933-938
20. Mandel J, Church T, Ederer F (1993) Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 328: 1365-1371 (Pubitemid 23131388)
21. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Sakaguchi K, Shiratori Y (2007) Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol 102: 2259-2264 (Pubitemid 47493843)
22. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y (2005) A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129: 422-428 (Pubitemid 41096630)
23. Noffsinger AE (2009) Serrated polyps and colorectal cancer new pathways to malignancy. Annu Rev Pathol 4: 343-364
24. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108 (Pubitemid 40372904)
25. Pignone M, Saha S, Hoerger T, Mandelblatt J (2002) Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137: 96-104 (Pubitemid 34779153)
26. Ransohoff DF (2009) How much does colonoscopy reduce colon cancer mortality? Ann Intern Med 150: 50-52
27. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM (1979) Adenomatous lesions of the large bowel: an autopsy survey. Cancer 43: 1847-1857 (Pubitemid 9203736)
28. Rockey DC (2010) Occult and obscure gastrointestinal bleeding: causes and clinical management. Nat Rev Gastroenterol Hepatol 7: 265-279
29. Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y (2009) Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment Pharmacol Ther 29: 906-917
30. Sacher-Huvelin S, Coron E, Gaudric M, Planche L, Benamouzig R, Maunoury V, Filoche B, Frédéric M, Saurin JC, Subtil C, Lecleire S, Cellier C, Coumaros D, Heresbach D, Galmiche JP (2010) Colon capsule endoscopy vs. colonoscopy in patients at average or increased risk of colorectal cancer. Aliment Pharmacol Ther 32: 1145-1153
31. Van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, Van Deventer SJ, Dekker E (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101: 343-350 (Pubitemid 43381678)
32. Williams AR, Balasooriya BA, Day DW (1982) Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 23: 835-842 (Pubitemid 12018511)
33. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, Van Ballegooijen M, Kuntz KM (2008) Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 149: 659-669